Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Core Laboratories (CLB) EBT (2022 - 2025)

Core Laboratories (CLB) has 4 years of EBT data on record, last reported at $18.3 million in Q3 2025.

  • For Q3 2025, EBT rose 9.48% year-over-year to $18.3 million; the TTM value through Sep 2025 reached -$4.8 million, down 110.53%, while the annual FY2024 figure was -$2.8 million, 106.83% down from the prior year.
  • EBT reached $18.3 million in Q3 2025 per CLB's latest filing, up from $12.6 million in the prior quarter.
  • Across five years, EBT topped out at $18.3 million in Q3 2025 and bottomed at -$37.5 million in Q4 2024.
  • Average EBT over 4 years is $7.3 million, with a median of $11.5 million recorded in 2023.
  • The widest YoY moves for EBT: up 67.1% in 2024, down 441.68% in 2024.
  • A 4-year view of EBT shows it stood at $12.5 million in 2022, then fell by 12.55% to $11.0 million in 2023, then plummeted by 441.68% to -$37.5 million in 2024, then skyrocketed by 148.8% to $18.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBT were $18.3 million in Q3 2025, $12.6 million in Q2 2025, and $1.8 million in Q1 2025.